These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9578169

  • 1. Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
    Shapiro MA, Sesnie JC, Desaty TM, Griffin TJ, Heifetz CL.
    J Antimicrob Chemother; 1998 Mar; 41(3):403-5. PubMed ID: 9578169
    [Abstract] [Full Text] [Related]

  • 2. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
    Pascual A A, Joyanes P, Martínez-Martínez L, del Carmen Conejo M, Hernández G, Chaves J, Perea EJ.
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121
    [Abstract] [Full Text] [Related]

  • 3. [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones].
    Díaz Valle D, Alós Cortés JI, Arteaga Sánchez A, Toledano Fernández N, Poza Morales Y, Díaz-Valle T.
    Arch Soc Esp Oftalmol; 2002 Jul; 77(7):397-9. PubMed ID: 12098814
    [Abstract] [Full Text] [Related]

  • 4. Comparative therapeutic efficacy of clinafloxacin in leucopenic mice.
    Shapiro MA, Dever JA, Sesnie JC, VanderRoest SR.
    J Antimicrob Chemother; 1997 Feb; 39(2):273-6. PubMed ID: 9069553
    [Abstract] [Full Text] [Related]

  • 5. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G, Pozzetto B, Dorche G.
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [Abstract] [Full Text] [Related]

  • 6. Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.
    Zelenitsky SA, Karlowsky JA, Hoban DJ, Kabani A, Zhanel GG.
    Chemotherapy; 1998 Mar; 44(1):1-6. PubMed ID: 9444401
    [Abstract] [Full Text] [Related]

  • 7. Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
    Kaneko Y, Yanagihara K, Kuroki M, Ohi H, Kakeya H, Miyazaki Y, Higashiyama Y, Hirakata Y, Tomono K, Kadota JI, Kohno S.
    Chemotherapy; 2001 Dec; 47(6):421-9. PubMed ID: 11786657
    [Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.
    Bakker-Woudenberg IA, ten Kate MT, Guo L, Working P, Mouton JW.
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2575-81. PubMed ID: 12121935
    [Abstract] [Full Text] [Related]

  • 9. Renal abscess due to Pseudomonas aeruginosa: report of two cases.
    Bampala S, Kollios K, Antachopoulos C, Tratselas A, Roilides E.
    Minerva Pediatr; 2013 Jun; 65(3):349-52. PubMed ID: 23685385
    [Abstract] [Full Text] [Related]

  • 10. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS, Pressler T, Jensen T, Rosdahl VT, Bentzon MW, Høiby N, Koch C.
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [Abstract] [Full Text] [Related]

  • 11. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [Abstract] [Full Text] [Related]

  • 12. Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.
    Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, Jackson JJ, Wiener-Kronish JP.
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2389-94. PubMed ID: 10508012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H, Zerouala C, Carrier M, Short B.
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E, Konkoly-Thege M, Kuti JL, Nicolau DP.
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [Abstract] [Full Text] [Related]

  • 17. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R, Fish DN, Obritsch MD, MacLaren R.
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
    Joo EJ, Kang CI, Ha YE, Kang SJ, Park SY, Chung DR, Peck KR, Lee NY, Song JH.
    Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.